Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Bleomycin vs Cryotherapy for Cutaneous Warts
NCT05023408Phase 2Completed
- Sponsor
- Jinnah Postgraduate Medical Centre
- Start
- Jan 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bleomycin in cutaneous warts (2 arms), sponsored by Jinnah Postgraduate Medical Centre. Primary endpoint: Change in morphology of cutaneous warts at 6 weeks. Started Jan 2021; status: completed.
02
Drugs
bleomycin
03
Conditions
cutaneous warts
Beyond the preview
Go deeper on NCT05023408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05023408.